Your browser doesn't support javascript.
loading
Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post-acute-care setting.
Zhang, Helen L; Gontjes, Kyle J; Han, Jennifer H; Alby, Kevin; Lapp, Zena; Snitkin, Evan; Goldstein, Ellie J C; Muldoon, Sean; Tolomeo, Pam; Lautenbach, Ebbing.
Afiliación
  • Zhang HL; Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Gontjes KJ; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Han JH; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Alby K; Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Lapp Z; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Snitkin E; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania.
  • Goldstein EJC; Department of Pathology and Lab Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Muldoon S; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.
  • Tolomeo P; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lautenbach E; R.M. Alden Research Laboratory, Santa Monica, California.
Infect Control Hosp Epidemiol ; 44(7): 1159-1162, 2023 Jul.
Article en En | MEDLINE | ID: mdl-35896514
ABSTRACT
We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed among 9.9% and 9.1% of isolates, respectively. Nonsusceptibility to ceftazidime-avibactam (1.1%) and plazomicin (0.8%) were uncommon.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ceftazidima / Klebsiella pneumoniae Límite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Asunto de la revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ceftazidima / Klebsiella pneumoniae Límite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Asunto de la revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Año: 2023 Tipo del documento: Article